Reaction Details |
| Report a problem with these data |
Target | Beta-2 adrenergic receptor |
---|
Ligand | BDBM50326546 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_658303 (CHEMBL1246860) |
---|
EC50 | 0.06±n/a nM |
---|
Citation | Glossop, PA; Lane, CA; Price, DA; Bunnage, ME; Lewthwaite, RA; James, K; Brown, AD; Yeadon, M; Perros-Huguet, C; Trevethick, MA; Clarke, NP; Webster, R; Jones, RM; Burrows, JL; Feeder, N; Taylor, SC; Spence, FJ Inhalation by design: novel ultra-long-actingß(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup. J Med Chem53:6640-52 (2010) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Beta-2 adrenergic receptor |
---|
Name: | Beta-2 adrenergic receptor |
Synonyms: | ADRB2 | ADRB2R | ADRB2_HUMAN | B2AR | Beta-2 adrenoceptor | Beta-2 adrenoreceptor |
Type: | n/a |
Mol. Mass.: | 46461.69 |
Organism: | Homo sapiens (Human) |
Description: | P07550 |
Residue: | 413 |
Sequence: | MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAK
FERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTAS
IETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQE
AINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRF
HVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQD
NLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNT
GEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
|
|
|
BDBM50326546 |
---|
n/a |
---|
Name | BDBM50326546 |
Synonyms: | CHEMBL402501 | N-adamantan-1-yl-2-(3-{(R)-2-[(R)-2-hydroxy-2-(4-hydroxy-3-hydroxymethyl-phenyl)-ethylamino]-propyl}-phenyl)-acetamide |
Type | Small organic molecule |
Emp. Form. | C30H40N2O4 |
Mol. Mass. | 492.6496 |
SMILES | C[C@H](Cc1cccc(CC(=O)NC23CC4CC(CC(C4)C2)C3)c1)NC[C@H](O)c1ccc(O)c(CO)c1 |THB:11:12:15:19.18.17,20:12:15:19.18.17,20:18:12.13.21:15,17:16:13:19.18.20,17:18:13:21.15.16| |
Structure |
|